Bentley has announced the successful first-in-human implantation of its recently CE-certified BeFlared stent graft system, which the company states is the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR).
The procedure was performed by Stéphan Haulon, MD, a vascular surgeon at the Hôpital Marie Lannelongue in Paris, France.
In a press release, Bentley detailed that Haulon implanted an aortic endoprosthesis through a small opening in the patient’s femoral artery, with three BeFlared stents then positioned at the fenestrations of the endograft, ensuring an immediate sealing and maintaining blood flow through the visceral arteries to vital organs. In addition, Haulon implanted one regular BeGraft stent at the fourth fenestration. The operation of the 72-year-old patient suffering from a severe aortic aneurysm ended after less than two hours.
“I am happy to report that the BeFlared met all our expectations regarding ease of use during the intervention, duration and matching the requirements of the patient’s anatomy,” Haulon summarized. “The recent certification of the BeFlared marks a milestone in the endovascular treatment of aortic aneurysms as it allows [us] to shorten procedure times and therefore reduce X-ray exposure to patients and operation staff significantly. This ‘two-in-one’ device creates a new standard for bridging stents in FEVAR procedures. The BeFlared is a gamechanger as it makes these interventions safer, faster and enables better outcomes for the patients. It was a pleasure and an honor for me and my team to be part of this development. I dearly thank all Bentley employees involved in the BeFlared project,” added Haulon, a Bentley medical advisors.
The BeFlared will be officially launched at next year’s Leipzig Interventional Course (LINC 2025; Jan. 28–30) in Leipzig, Germany, Bentley stated. It will become commercially available as of Feb. 3, in line with country-specific market regulations.
